These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12850329)

  • 1. Multisite clinical trials in strict accordance with GMP standards?
    Poe TA
    Drug Discov Today; 2003 Jul; 8(13):570-3. PubMed ID: 12850329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 3. The US Food and Drug Administration's use of regular approval for cancer drugs based on single-arm studies: implications for subsequent evidence generation.
    DeLoughery EP; Prasad V
    Ann Oncol; 2018 Mar; 29(3):527-529. PubMed ID: 29346605
    [No Abstract]   [Full Text] [Related]  

  • 4. Who watches the watchmen?
    Nature; 2011 Aug; 476(7359):125. PubMed ID: 21833048
    [No Abstract]   [Full Text] [Related]  

  • 5. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry looks to buck bias in emerging 'adaptive' designs.
    Torres C
    Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526301
    [No Abstract]   [Full Text] [Related]  

  • 7. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 8. Institutional review boards: a crisis in confidence.
    Levine RJ
    Ann Intern Med; 2001 Jan; 134(2):161-3. PubMed ID: 11177321
    [No Abstract]   [Full Text] [Related]  

  • 9. A US Food and Drug Administration perspective on evaluating medical products for Ebola.
    Russek-Cohen E; Rubin D; Price D; Sun W; Cox E; Borio L
    Clin Trials; 2016 Feb; 13(1):105-9. PubMed ID: 26768565
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA under pressure to relax drug rules.
    Ledford H
    Nature; 2012 Dec; 492(7427):19. PubMed ID: 23222585
    [No Abstract]   [Full Text] [Related]  

  • 11. Today's FDA.
    Slater EE
    N Engl J Med; 2005 Jan; 352(3):293-7. PubMed ID: 15659733
    [No Abstract]   [Full Text] [Related]  

  • 12. The needs of the few.
    Nature; 2010 Jul; 466(7303):160. PubMed ID: 20613796
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress and deficiencies in the registration of clinical trials.
    Wood AJ
    N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628
    [No Abstract]   [Full Text] [Related]  

  • 14. Surrogate Endpoints in Pediatric Studies Submitted to the US FDA.
    Green DJ; Sun H; Burnham J; Liu XI; van den Anker J; Temeck J; Yao L; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2019 Mar; 105(3):555-557. PubMed ID: 30094815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. News from the Society for Women's Health Research: FDA doing poor job of monitoring drugs for sex differences.
    Greenberger P
    J Womens Health Gend Based Med; 2001 Nov; 10(9):829-30. PubMed ID: 11747675
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuft's report backs FDA fast-track, but post-marketing concerns loom.
    Vastag B
    Nat Biotechnol; 2006 May; 24(5):478. PubMed ID: 16680113
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid reporting and review of an increased incidence of a known adverse event.
    Sargent DJ; Goldberg RM; Mahoney MR; Hillman DW; McKeough T; Hamilton SF; Darcy JM; Anderson VL; Krook JE; O'Connell MJ
    J Natl Cancer Inst; 2000 Jun; 92(12):1011-3. PubMed ID: 10861314
    [No Abstract]   [Full Text] [Related]  

  • 19. Children's oncology group looks to increase efficiency, numbers in clinical trials.
    Benowitz S
    J Natl Cancer Inst; 2000 Dec; 92(23):1876-8. PubMed ID: 11106677
    [No Abstract]   [Full Text] [Related]  

  • 20. European investigational antiepilepsy drug trials.
    Sussman NM
    Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.